Saturn V Capital Management provides investment advice to investment funds, primarily focusing on biotechnology companies. Saturn V uses statistical modeling to predict the outcomes of drug candidate clinical trials and invests in companies it believes are likely to have positive or negative results. The firm manages money on a discretionary basis for these funds.
Assets Under Management$420M
Clients3
Advisors1
Avg. per Client$140M
Avg. per Advisor$420M
Fee Structure
Minimum Investment:$1M
Investment management only (planning not offered)
Detailed fee information is not available for this advisor. View their full brochure on SEC.gov for fee details.
Loading...